Bladder Cancer

Trial Protocol ID
USOR 22093_XB002-101_Jewel-101

Investigator
Yousuf A. Gaffar, M.D.

A DOSE-ESCALATION AND EXPANSION STUDY OF THE SAFETY AND PHARMACOKINETICS OF XB002 AS SINGLE-AGENT AND COMBINATION THERAPY IN SUBJECTS WITH INOPERABLE LOCALLY ADVANCED OR METASTATIC SOLID TUMORS (XB002-101)

Learn More

Trial Protocol ID
USOR 18283_IMMU-132-06_TROPHY U-01

Investigator
Jun Sun, M.D.

A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer
Learn More